Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-022747
Filing Date
2025-08-22
Accepted
2025-08-22 16:07:24
Documents
1
Period of Report
2025-08-20

Document Format Files

Seq Description Document Type Size
1 form4-08222025_080818.html 4  
1 form4-08222025_080818.xml 4 5774
  Complete submission text file 0001415889-25-022747.txt   7169
Mailing Address 501 2ND STREET SUITE 211 SAN FRANCISCO CA 94107
Business Address
Seely Lynn (Reporting) CIK: 0001327111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 251246311

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)